|
| Exchange Disseminated Time 10/11/2016 15:55:09 | Sun Pharmaceutical Industries Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 10, 2016, has approved subject to receipt of further approvals of the hon’ble High Court of Gujarat or the National Company Law Tribunal (“High Court”), as the case may be, Stock Exchanges, Securities and Exchange Board of India and all other requisite parties/authorities, the Scheme of Arrangement for amalgamation of Sun Pharma Medisales Private Limited, Ranbaxy Drugs Limited, Gufic Pharma Limited and Vidyut Investments Limited, which are direct or indirect wholly owned subsidiaries of the Company, into Sun Pharmaceutical Industries Limited in terms of Sections 391 to 394 or any other applicable provisions, if any, of the Companies Act, 1956 and/or the corresponding provisions of Companies Act, 2013 (“Scheme”), as the case may be, with appointed date of April 01, 2017 or such other date as may be agreed/required by the Transferor Companies and the Transferee Company and/or by the High Court.
The meeting of the Board of Directors commenced on November 10, 2016 at 11:00 a.m. and concluded at 03:25 p.m. |
|
|